ESR1 and breast cancer: According to the statuses of four molecular biomarkers, namely, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki67, BC can be classified into four main intrinsic subtypes: luminal A, luminal B, HER2-enriched, and triple-negative (1, 8).